ArticleCancer immunology, immunotherapy : CII2016

Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.